|
|
Volumn 10, Issue 4, 2004, Pages 356-
|
|
Step-therapy edits for PPIs and COX-2 drugs. What we do and do not know.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ISOENZYME;
MEMBRANE PROTEIN;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTON PUMP;
PTGS2 PROTEIN, HUMAN;
COST BENEFIT ANALYSIS;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
ECONOMICS;
HUMAN;
NOTE;
ORGANIZATION AND MANAGEMENT;
PHARMACY;
COST-BENEFIT ANALYSIS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PHARMACEUTICAL SERVICES;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROTON PUMPS;
MLCS;
MLOWN;
|
|
EID: 5144232070
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: 10.18553/jmcp.2004.10.4.356 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
